Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why XBiotech Shares Are Skyrocketing 32.7% Today

After the company announced that it will repurchase up to $420 million of its shares at a price no lower than $30 nor higher than $33 apiece, shares in XBiotech (NASDAQ: XBIT) are surging 32.7%


After the company announced that it will repurchase up to $420 million of its shares at a price no lower than $30 nor higher than $33 apiece, shares in XBiotech (NASDAQ: XBIT) are surging 32.7% higher at 3:00 pm EST on Tuesday.

The share repurchase follows Johnson & Johnson's (NYSE: JNJ) acquisition of XBiotech's only clinical-stage asset, bermekimab, for $750 million in December.

IMAGE SOURCE: GETTY IMAGES.

Continue reading


Source Fool.com

Like: 0
Share

Comments

You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more